Search form

Scroll To Top

hiv awareness

​The Food and Drug Administration has approved lenacapavir, a breakthrough medication that reduces the risk of contracting HIV by 96 percent
Health

FDA approves breakthrough drug that reduces risk of contracting HIV by 96 percent

Otherwise known by its generic name lenacapavir (LEN), Yeztugo has been approved after nearly eliminating the spread of HIV among trial patients.

Aids Red Ribbon
Voices

From awareness to action: Mobilizing for HIV/AIDS awareness days

National HIV/AIDS Awareness Days play a pivotal role in breaking down the stigma associated with HIV, fostering crucial conversations and actions aimed at ending the epidemic through targeted outreach and education across diverse communities.